Owlet OWLT
NYSE OWLT
$5.61 -0.18 (-3.20%)
As of: Aug 20, 2026 · 3:59 PM EDT

Owlet (OWLT) Operating Leases (2022 - 2023)

Owlet (OWLT) posted quarterly Operating Leases of $1.2 million for Q4 2023, up 2.5% year-over-year from $1.2 million in Q4 2022, and up 1554.17% quarter-over-quarter from $72000.0 in Q3 2023.

Owlet (OWLT) Operating Leases (2022 - 2023) Analysis & Trends

Owlet (OWLT) has reported Operating Leases for 2 consecutive years, with $1.2 million the latest figure, recorded in Q4 2023.

  • In Q4 2023, Operating Leases rose 2.5% year-over-year to $1.2 million; the TTM figure through Dec 2023 stood at $1.2 million (up 2.5% YoY), while the FY2023 annual figure was $1.2 million, up 2.5% from the prior year.
  • Operating Leases rose to $1.2 million in Q4 2023 per OWLT's latest filing, from $72000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $3.4 million in Q1 2022 and bottomed at $72000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Owlet 159.40 Mn 122.85 Mn 21.82 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 1.19 Mn
Sep 30, 2023 72,000.00
Jun 30, 2023 265,000.00
Mar 31, 2023 715,000.00
Dec 31, 2022 1.16 Mn
Sep 30, 2022 3.22 Mn
Jun 30, 2022 2.11 Mn
Mar 31, 2022 3.44 Mn